ZETA · Zeta Global Holdings Corp
Price
Snapshot
50 fields · last close| Market Cap | $5.33B |
| P/E | — |
| Float | 221.2M |
| Beta | 1.28 |
| Volatility | 31.9% |
| Exchange | NYSE |
| Sector | Technology |
| Cap tier | Mid cap |
| Macro sensitivity | High |
| Clavix score | 54.5 |
| Price | 34.86 |
| Change | +3.90% |
| Prev Close | 33.55 |
| Open | 32.65 |
| Day Low | 32.54 |
| Day High | 33.87 |
| Avg Vol | 6 |
| Avg $ Vol | $211.7M |
| 52W High | 35.75 |
| 52W Low | 14.37 |
| 52W Pos | 95.8% |
| From High | −2.49% |
| From Low | +142.67% |
| Max DD 1Y | −40.37% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +8.93% |
| SMA 50 | +13.31% |
| SMA 200 | +57.72% |
| RSI (14) | 58.9 |
| Vol 30D | 42.7% |
| Vol 90D | 56.0% |
| 1Y Range | 14–36 |
| Daily bars | 538 |
| Perf Week | −0.74% |
| Perf Month | +7.70% |
| Perf Quarter | +66.25% |
| Perf Half Y | +88.38% |
| Perf Year | +88.27% |
| Perf YTD | +75.09% |
| Prev Day | +3.90% |
| Clavix | C- |
| Debt / Eq | 0.24 |
| Curr Ratio | 1.60 |
| Int Cover | -2.9× |
| FCF Margin | 14.2% |
| Rev Growth | +29.7% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 49 / 100 |
Clavix risk grade
regraded every trading dayZETA grades C-, 54.5 of 100. Steadiest on Sector Resilience (72), most exposed on Macro Resilience (29, weak). 3 of the 4 weighted dimensions sit above the Technology median. Ranks 49 of 100 in Technology by Clavix score.
How rough the ride is
| ZETA | Technology median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.28 | 1.28 |
| Volatilityannualized | 31.9% | 32.2% |
| Max drawdown, past yearworst peak-to-trough fall | −40.4% | — |
| Typical daily movemedian absolute daily change | 2.19% | — |
| Days beyond ±3%of the last 252 sessions | 113 (45%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ZETA | Technology median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.28 | 1.28 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate 39% of 102 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Technology names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ZETA | |
|---|---|
| 1 week | −0.7% |
| 1 month | +7.7% |
| Year to date | +75.1% |
| 1 year | +88.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ZETA | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 26 Sep |
| Average score0 most bearish, 100 most bullish | 70 |
| Bullish · bearisharticles above 60 · below 40 | 28 · 2 |
| Directionarticles whose tone is improving vs worsening | 28 ↑ 2 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 100 Technology names Clavix covers; the tick is the sector median.
Growth
| ZETA | |
|---|---|
| Revenue growthyear over year | +29.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Technology median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openZeta Surgical (ZETA) announced a collaboration with DARPA to run a Phase 3 clinical study called SPARC-TMS. The study will test the company's robotic, image-guided system for delivering transcranial magnetic stimulation (a non-invasive brain treatment using magnetic pulses) to patients in a single clinic visit.
Zeta Surgical announced it has launched a collaboration with the U.S. Defense Advanced Research Projects Agency (DARPA) to support the Phase 3 SPARC-TMS clinical study. The study will test the company's robotic, image-guided transcranial magnetic stimulation (TMS, a non-invasive treatment that uses magnetic pulses to affect brain activity) given to patients in a single outpatient visit.
A law firm is advertising to ZETA shareholders, inviting them to contact the firm about possible claims that company insiders breached their fiduciary duties. No actual lawsuit, investigation outcome, or ruling is described, it is a solicitation for clients on a no-cost-until-you-win basis.
Several analysts updated their ratings and price targets for Zeta Global in mid-October 2026. Craig Hallum set a new $38.00 price target on October 12, and Roth Capital reaffirmed its 'buy' rating while raising its price target to $55.00 from $44.00. Additional entries were truncated and not visible.
Zeta Global is acquiring Senso, the startup that supplies the technology behind its tool for tracking brands across AI platforms like ChatGPT, Gemini, and Claude. No purchase price was disclosed.
Nearest peers by size
Technology| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| RIOT | Riot Platforms Inc | D- | $5.17B | — | 3.97 | Compare |
| ACIW | ACI Worldwide Inc | B+ | $5.51B | 23.36 | 1.01 | Compare |
| VRNS | Varonis Systems Inc | C+ | $5.60B | — | 0.73 | Compare |
| BOX | Box Inc | B+ | $5.73B | 42.48 | 0.69 | Compare |
| APLD | Applied Digital Corp | F | $5.85B | — | 5.56 | Compare |
| QBTS | D-Wave Quantum Inc | F | $4.47B | — | 2.28 | Compare |
| CORZ | Core Scientific Inc | D | $4.43B | — | 4.02 | Compare |
| TENB | Tenable Holdings Inc | C- | $4.29B | 640.80 | 0.94 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.